The effects of imidazoline agents on the aggregation of human platelets

Journal of Pharmacy and Pharmacology

Volumn 56, Issue 2, 2004, Pages 213-220

  Pinthong, Darawan ^a   Songsermsakul, Piyada ^a   Rattanachamnong, Piyanee ^a   Kendall, David A ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXY 2 METHYLBENZALDEHYDE 2 IMIDAZOLIN 2 YLHYDRAZONE; ADENOSINE DIPHOSPHATE; ADRENALIN; AGMATINE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTAZOLINE; BETA CARBOLINE; CATECHOLAMINE; CITRATE SODIUM; CLONIDINE; CLONIDINE DERIVATIVE; CLONIDINE DISPLACING SUBSTANCE; EFAROXAN; HARMAN; IDAZOXAN; IMIDAZOLINE; IMIDAZOLINE RECEPTOR; KUM 32; LIGAND; MOXONIDINE; NORADRENALIN; RILMENIDINE; SEROTONIN; TOLAZOLINE; UNCLASSIFIED DRUG; VASOPRESSIN; YOHIMBINE;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DEVICE; DRUG BINDING SITE; DRUG POTENCY; DRUG POTENTIATION; HUMAN; HUMAN CELL; THROMBOCYTE AGGREGATION; TURBIDIMETRY; VOLUNTEER;

ADENOSINE DIPHOSPHATE; ADRENERGIC ALPHA-AGONISTS; ANIMALS; CLONIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; HUMANS; NOREPINEPHRINE; PLATELET AGGREGATION; RECEPTORS, ADRENERGIC, ALPHA-2; SWINE;

EID: 1242308935     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357022593     Document Type: Article

References (47)

1. Ardlie, N. G., Glew, G., Schwartz, C. J. (1966) Influence of catecholamines on nucleotide-induced platelet aggregation. Nature (London) 212: 415-416
2. Atlas, D. (1990) Clonidine-displacing substance (CDS) and its putative imidazoine receptor. Biochem. Pharmacol. 41: 1541-1549
3. Atlas, D., Burstein, Y. (1984) Isolation and partial purification of a clonidine-displacing endogenous brain substance. Eur. J. Pharmacol. 144: 287-293
4. Banga, S. H., Simons, E. R., Brass, L. F., Rittenhouse, S. E. (1986) Activation of phospholipase A and C in human platelets exposed to epinephrine; role of glycoproteins IIb/IIIa and dual role of epinephrine. Proc. Natl Acad. Sci. USA 83: 9197-9201
5. Berdeu, D., Gross, R., Puech, R., Loubatières-Mariani, M.-M., Bertrand, G. (1995) Evidence for two different imidazoline sites on pancreatic B cells and vascular bed in rat. Eur. J. Pharmacol. 275: 91-98
6. Bricca, G., Dontenwill, M., Molines, A., Feldman, J., Tibirica, E., Belcourt, A., Bousquet, P. (1989) Rilmenidine selectivity for imidazoline receptors in human brain. Eur. J. Pharmacol. 163: 373-377
7. Chapleo, C. B., Myers, P. L., Budler, R. C. M., Davis, J. A., Doxey, J. C., Higgins, S. D., Myers, M., Roach, A. G., Smith, C. F. C., Stillings, M. R., Welbourn, A. P. (1984) α-Adrenoceptor reagents 2. Effects of modification of the 1,4-benzodioxan ring system on α-adrenoceptor activity. J. Med. Chem. 27: 570-576
8. Clare, K. A., Scrutton, M. C., Thompson, N. T. (1984) Effect of alpha-2-adrenoceptor agonists and of related compounds on aggregation of, and on adenylate cyclase activity in human platelets. Br. J. Pharmacol. 82: 467-476
9. Culliver, H. A., Ardlie, N. G. (1981) Human platelet aggregation in response to multiple agonists in plasma anticoagulated with heparin. Thromb. Haemost. 46: 205
10. Cusack, N., Hourani, S. M. O. (1982) Differential inhibition by adenosine or by prostaglandinE1 of human platelet aggregation induced by adenosine 5′-O-(1-thiodiphosphate) and adenosine 5′-O-(2-thiodiphosphate). Br. J. Pharmacol. 75: 257-259
11. 2-adrenoceptors of human platelets. Eur. J. Pharmacol. 144: 247-255
12. Eglen, R. M., Hudson, A. L., Kendall, D. A., Nutt, D. J., Morgan, N. G., Wilson, V. G., Dillon, M. P. (1998) 'Seeing through a glass darkly': casting tight on imidazoline 'I' sites. Trends Pharmacol. Sci. 19: 381-390
13. 2-adrenoceptors in the ventrolateral medulla. Eur. J. Pharmacol. 134: 1-13
14. 1-imidazoline receptors. J. Cardiovasc. Pharmacol. 20: S1-S10
15. 1-Imidazoline receptors: definition, characterization, distribution and transmembrane signaling. Ann. N. Y. Acad. Sci. 763: 22-42
16. 1, Forskolin). Biochem. Biophys. Res. Commun. 113: 598-604
17. 2-adrenergic activity. Biochem. Pharmacol. 35: 1511-1516
18. Glusa, E., Markwardt, F. (1980) Adrenaline-induced reactions of human platelets in hirudin plasma. Haemostasis 9: 188-192
19. 2-adrenoceptors primarily responsible for inducing human platelet aggregation, Nature, 277: 659-661
20. 1 imidazoline receptors to the cAMP pathway: studies with a highly selective ligand, benazoline. Mol. Pharmacol. 57: 1142-1151
21. Haslam, R. J., Davidson, M. M., Desjardins, J. V. (1978) Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP. Biochem. J. 176: 83-95
22. Hsu, C. Y., Knapp, D. R., Halushka, P. Y. (1979) The effects of alpha-adrenergic agents on human platelet aggregation. J. Pharmacol. Exp. Ther. 208: 366-370
23. Hudson, A. L. (1999) Harmane, norharmane and tetrahydro β-carboline have high affinity for rat imidazoline binding sites. Br. J. Pharmacol. 126: 2P
24. Hudson, A. L., Gough, R., Tyacke, R., Lione, L., Lalies, M., Lewis, J., Husbands, S., Knight, P., Murray, F., Hutson, P., Nutt, J. (1999) Novel selective compounds for the investigation of imidazoline receptors. Ann. N. Y. Acad. Sci. 881: 81-91
25. Jin, J., Kunapuli, S. P. (1998) Coactivation of two different G-protein coupled receptors is essential for ADP-induced platelet aggregation. Proc. Natl Acad. Sci. 95: 8074-8076
26. Jin, J., Daniel, J. L., Kunapuli, S. P. (1998) Molecular basis for ADP-induced platelet aggregation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. J. Biol. Chem. 273: 2030-2034
27. 3H-yohimbine binding with the potentiation by adrenaline on ADP-induced aggregation. Thromb. Haemost. 54: 402-408
28. Lasch, P., Jakobs, K. H. (1979) Agonistic and antagonistic effects of various α-adrenergic agonists in human platelets. Naunyn Schmiedebergs Arch. Pharmacol. 306: 119-125
29. Li, G., Regunathan, S., Barrow, C. J., Eshraghi, J., Cooper, R., Reis, D. J. (1994) Agmatine: an endogenous clonidine-displacing substance in the brain. Science 263: 966-969
30. Michel, M. C., Ernsberger, P. (1992) Keeping an eye on the I site: imidazoline-preferring receptors. Trends Pharmacol. Sci. 13: 369-370
31. Molderings, G. J., Burain, M., Menzel, S., Donecker, K., Homann, J., Nilius, M., Gothert, M. (1999) Imidazoline recognition sites and stomach function. Ann. N. Y. Acad. Sci. 881: 332-343
32. 3H]-yohimbine. Biochem. Biophys. Res. Commun. 97: 1562-1570
33. Musgrave, I. F., Badoer, E. (2000) Harmane produces hypotension following microinjection into the RVLM: possible role of I(1)-imidazoline receptors. Br. J. Pharmacol. 129: 1057-1059
34. Piletz, J. E., Sletten, K. (1993) Non-adrenergic imidazoline binding sites on human platelets. J. Pharmacol. Exp. Ther. 267: 1493-1502
35. 2-adrenoceptor states plus a non-adrenergic site on human platelet plasma membranes. Biochem. Pharmacol. 42: 569-584
36. 2-adrenoceptor. Thai J. Pharmacol. 23: 207-218
37. 2-adrenoceptor binding sites. Br. J. Pharmacol. 115: 689-695
38. Regunathan, S., Evinger, M. J., Meeley, M. P., Reis, D. J. (1991) Effects of clonidine and other imidazole-receptor binding agents on second messenger systems and calcium influx in bovine adrenal chromaffin cells. Biochem. Pharmacol. 42: 2011-2018
39. Sage, S. O., Rink, T. J. (1987) The kinetics of changes in intracellular calcium concentration in fura-2 loaded human platelets. J. Biol. Chem. 262: 16364-16369
40. Sanders, J., Miller, D. D., Patil, P. N. (1975) Alpha-adrenergic and histaminergic effects of tolazoline-like imidazolines. J. Pharmacol. Exp. Ther. 195: 362-371
41. Schultz, A., Hasselblatt, A. (1989) An insulin releasing property of imidazoline derivatives is not limited to compounds that block α-adrenoceptor. Naunyn Schmiedebergs Arch. Pharmacol. 340: 321-327
42. 3H]-clonidine. Mol. Pharmacol. 19: 179-183
43. Singh, G., Hussain, J. F., MacKinnon, A., Brown, C. M., Kendall, D. A., Wilson, V. G. (1995) Evidence for the presence of a non-catecholamine, clonidine-displacing substance in crude, methanolic extracts of bovine brain and lung. Naunyn Schmiedebergs Arch. Pharmacol. 351: 17-26
44. 2-adrenergic receptor on intact human blood platelets. J. Lab. Clin. Med. 102: 779-787
45. Synetose, D., Manolopoulous, V. G., Atlas, D., Synetose, E. P. (1991) Human plasma-derived material with clonidine displacing substance (CDS)-like properties contracts the isolated rat aorta. J. Auton. Pharmacol. 11: 343-351
46. Tranquilli, W. J., Thurmon, J. C. (1984) Alpha adrenoceptor pharmacology. JAVMA 184: 1400-1402
47. Vial, C., Hechler, B., Leon, C., Cazenave, J.-P., Gachet, C. (1997) Presence of P2X1 purinoceptors in human platelets and megakaryoblastic cell lines. Thromb. Haemost. 78: 1500-1504